Tazarotene 0.1% Gel in Combination with Mometasone Furoate Cream in Plaque Psoriasis: A Photographic Tracking Study

Cutis

Volumn 63, Issue 1, 1999, Pages 41-48

  Poulin, Yves P ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b Centre Dermatologique du Quebec Metropolitain   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT; GLUCOCORTICOID; KERATOLYTIC AGENT; MOMETASONE FUROATE; NICOTINIC ACID DERIVATIVE; PREGNANE DERIVATIVE; RETINOID; TAZAROTENE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; GEL; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PATIENT SATISFACTION; PHOTOGRAPHY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; TIME; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GELS; GLUCOCORTICOIDS; HUMANS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; NICOTINIC ACIDS; PATIENT SATISFACTION; PHOTOGRAPHY; PREGNADIENEDIOLS; PSORIASIS; REMISSION INDUCTION; RETINOIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032611090     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chandraratna RAS: Tazarotene - first of a new generation of receptor-selective retinoids. Br J Dermatol 135: 18-25, 1996.
2. Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, et al: Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol 30: 581-590, 1994.
3. Nagpal S, Patel S, Asano AT, et al: Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol 106: 269-274, 1996.
4. Nagpal S, Patel S, Jacobe H, et al: Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol 109(1): 91-95, 1997.
5. Duvic M, Nagpal S, Asano AT, et al: Molecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol 37: S18-S24, 1997.
6. Phillips WG, Breathnach SM: Psoriasis: immune indicators and treatment. Drugs 1(2): 157-167, 1994.
7. Weinstein GD, Krueger GG, Lowe NJ, et al: Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 37: 85-92, 1997.
8. Lebwohl MG, Breneman DL, Goffe BS, et al: Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol 39: 590-596, 1998.